Levothyroxine Sodium 1 A Pharma Gmbh

Levothyroxine Sodium, the active ingredient in Levothyroxine Sodium 1 A Pharma Gmbh, is a thyroid hormone presented as an oral tablet for oral use. It replaces deficient thyroid hormone and is used to treat hypothyroidism, goiter, and other conditions requiring thyroid hormone replacement. GNH USA supplies Levothyroxine Sodium 1 A Pharma Gmbh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levothyroxine Sodium is a synthetic thyroid hormone used to restore normal metabolic function in disorders of thyroid hormone deficiency. - Hypothyroidism: normalises low thyroid hormone levels and alleviates associated fatigue, weight gain and cold intolerance. - Goiter: reduces thyroid‑stimulating hormone drive, helping to shrink an enlarged thyroid gland. - Thyroid hormone replacement therapy: provides a stable source of T4 for patients after thyroidectomy or radioactive iodine treatment.

Levothyroxine Sodium may cause a range of adverse reactions, most of which are dose‑related and reversible upon adjustment.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Insomnia: difficulty falling or staying asleep. - Palpitations: sensation of rapid or irregular heartbeat. - Weight loss: unintended reduction in body weight. - Heat intolerance: increased sensitivity to warm environments. - Tremor: fine shaking of the hands.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm, especially in patients with pre‑existing heart disease. - Angina pectoris: chest pain due to reduced coronary blood flow. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Bone loss (osteoporosis): prolonged excess thyroid hormone may reduce bone mineral density. - Hyperthyroidism symptoms: excessive dose can cause anxiety, sweating, and menstrual irregularities.

Levothyroxine Sodium requires careful monitoring and individualized dosing to avoid over‑ or under‑replacement. - Thyroid function monitoring: regularly check serum TSH and free T4 levels to guide dose adjustments. - Cardiovascular disease: start with low doses and titrate slowly in patients with angina or arrhythmias. - Elderly patients: consider reduced initial dose due to increased sensitivity. - Pregnancy and lactation: use only if clearly needed; discuss risks with a healthcare professional. - Drug discontinuation: avoid abrupt stopping; taper under medical supervision. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Levothyroxine Sodium can interact with several medicines, altering its absorption or systemic effects.

Major Interactions (Avoid): - Calcium supplements: bind levothyroxine in the gut, reducing absorption. - Iron salts: significantly decrease oral bioavailability. - Sucralfate: forms insoluble complexes, impairing uptake. - Cholestyramine and other bile‑acid sequestrants: lower serum levothyroxine concentrations. - Antacids containing aluminum or magnesium: interfere with absorption.

Moderate Interactions (Monitor Closely): - Warfarin: levothyroxine may enhance anticoagulant effect; monitor INR. - Oral contraceptives: may increase levothyroxine binding proteins, requiring dose review. - Diabetes medications: thyroid hormone changes can affect glucose control. - Antidepressants (SSRIs, tricyclics): may require dose adjustments. - Statins: monitor for potential changes in lipid profile.